Novartis AG is 258.3x more valuable than MANNKIND CORP by market capitalization ($292.08 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MNKD | NVS |
|---|---|---|
| Market cap | $1.13 B | $292.08 B |
| US-listed rank | #2561 | #47 |
| Revenue (latest FY) | $348.97M | - |
| Net income (latest FY) | $5.86M | - |
| Net margin | 1.7% | - |
| P/E (trailing FY) | 192.9 | - |
| SEC filings | 1,648 | 947 |
Novartis AG is 258.3x more valuable than MANNKIND CORP by market capitalization ($292.08 B vs $1.13 B).
Full pages: MANNKIND CORP and Novartis AG, or browse the full rankings.